Cargando…

Insulin-Like Growth Factor Binding Protein 2 Is Associated With Biomarkers of Alzheimer’s Disease Pathology and Shows Differential Expression in Transgenic Mice

There is increasing evidence that metabolic dysfunction plays an important role in Alzheimer’s disease (AD). Brain insulin resistance and subsequent impairment of insulin and insulin-like growth factor (IGF) signaling are associated with the neurodegenerative and clinical features of AD. Nevertheles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonham, Luke W., Geier, Ethan G., Steele, Natasha Z. R., Holland, Dominic, Miller, Bruce L., Dale, Anders M., Desikan, Rahul S., Yokoyama, Jennifer S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055061/ https://www.ncbi.nlm.nih.gov/pubmed/30061810 http://dx.doi.org/10.3389/fnins.2018.00476

Ejemplares similares

The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
por: Bonham, Luke W., et al.
Publicado: (2016)

Rates of Decline in Alzheimer Disease Decrease with Age
por: Holland, Dominic, et al.
Publicado: (2012)

Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
por: Holland, Dominic, et al.
Publicado: (2012)

Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case–control study
por: Steele, Natasha Z. R., et al.
Publicado: (2017)

Age‐dependent effects of APOE ε4 in preclinical Alzheimer's disease
por: Bonham, Luke W., et al.
Publicado: (2016)

Genetic Variation in the Androgen Receptor and Measures of Plasma Testosterone Levels Suggest Androgen Dysfunction in Alzheimer’s Disease
por: Carr, Jessie S., et al.
Publicado: (2018)

Protein network analysis reveals selectively vulnerable regions and biological processes in FTD
por: Bonham, Luke W., et al.
Publicado: (2018)

Rare TREM2 variants associated with Alzheimer’s disease display reduced cell surface expression
por: Sirkis, Daniel W., et al.
Publicado: (2016)

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia
por: Bonham, Luke W., et al.
Publicado: (2019)

Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
por: Mantyh, William G., et al.
Publicado: (2023)

Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease
por: Kauppi, Karolina, et al.
Publicado: (2018)

Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
por: Desikan, Rahul S, et al.
Publicado: (2013)

C9orf72 gene networks in the human brain correlate with cortical thickness in C9-FTD and implicate vulnerable cell types
por: Broce, Iris J., et al.
Publicado: (2023)

Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease
por: Yokoyama, Jennifer S, et al.
Publicado: (2015)

Metformin Ameliorates Aβ Pathology by Insulin-Degrading Enzyme in a Transgenic Mouse Model of Alzheimer's Disease
por: Lu, Xin-Yi, et al.
Publicado: (2020)

CXCR4 involvement in neurodegenerative diseases
por: Bonham, Luke W., et al.
Publicado: (2018)

Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score
por: Desikan, Rahul S., et al.
Publicado: (2017)

Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
por: Sirkis, Daniel W., et al.
Publicado: (2022)

Beyond SNP heritability: Polygenicity and discoverability of phenotypes estimated with a univariate Gaussian mixture model
por: Holland, Dominic, et al.
Publicado: (2020)

Transgenic mice overexpressing human G972R IRS-1 show impaired insulin action and insulin secretion.
por: Hribal, Marta L, et al.
Publicado: (2008)

A transgenic minipig model of Huntington's disease shows early signs of behavioral and molecular pathologies
por: Askeland, Georgina, et al.
Publicado: (2018)

CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models
por: Laporte, Vincent, et al.
Publicado: (2006)

Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease
por: Desikan, Rahul S., et al.
Publicado: (2010)

Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model
por: Wang, Xu, et al.
Publicado: (2010)

Upregulation of Prickle2 Ameliorates Alzheimer’s Disease-Like Pathology in a Transgenic Mouse Model of Alzheimer’s Disease
por: Sun, Fengxian, et al.
Publicado: (2020)

Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathy
por: Sirkis, Daniel W., et al.
Publicado: (2023)

Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis
por: Oh, Kwang-Jin, et al.
Publicado: (2010)

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
por: Paris, Daniel, et al.
Publicado: (2010)

Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
por: Barilar, Jelena Osmanovic, et al.
Publicado: (2020)

APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice
por: Balu, Deebika, et al.
Publicado: (2023)

Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
por: Berlanga-Acosta, Jorge, et al.
Publicado: (2020)

Comparative study of rivastigmine and galantamine on the transgenic Drosophila model of Alzheimer's disease
por: Siddique, Yasir Hasan, et al.
Publicado: (2022)

Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice
por: Hiltunen, Mikko, et al.
Publicado: (2012)

Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
por: Ke, Yazi D., et al.
Publicado: (2009)

Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models
por: Blurton-Jones, Mathew, et al.
Publicado: (2014)

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
por: Schemmert, Sarah, et al.
Publicado: (2018)

Alzheimer’s Disease-Associated Pathology in a Transgenic Mouse Model Results in Altered Voiding Function
por: Hardy, Cara, et al.
Publicado: (2020)

Natural Bioactive Products and Alzheimer’s Disease Pathology: Lessons from Caenorhabditis elegans Transgenic Models
por: Navarro-Hortal, María D., et al.
Publicado: (2022)

Transfixed by transgenics: how pathology assumptions are slowing progress in Alzheimer's disease and related dementia research
por: D'Adamio, Luciano
Publicado: (2023)

Transgenic mice with ectopic expression of constitutively active TLR4 in adipose tissues do not show impaired insulin sensitivity
por: Ono‐Moore, Kikumi D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9ibo5dcau724d0mkv2eqa28aj2